{"parse":{"title":"Research on Adverse Drug Events and Reports","pageid":12667794,"revid":753200215,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-content ambox-Unreferenced\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>does not <a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\">cite</a> any <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">sources</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Research_on_Adverse_Drug_Events_and_Reports&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and <a href=\"/wiki/Wikipedia:Verifiability#Burden_of_evidence\" title=\"Wikipedia:Verifiability\">removed</a>.</span>  <small><i>(December 2016)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"vertical-navbox nowraplinks\" style=\"float:right;clear:right;width:22.0em;margin:0 0 1.0em 1.0em;background:#f9f9f9;border:1px solid #aaa;padding:0.2em;border-spacing:0.4em 0;text-align:center;line-height:1.4em;font-size:88%\"><tbody><tr><th style=\"padding:0.2em 0.4em 0.2em;font-size:145%;line-height:1.2em\">Regulation of therapeutic goods in the United States</th></tr><tr><td style=\"padding:0.2em 0 0.4em\"><a href=\"/wiki/File:Ritalin-SR-20mg-1000x1000.jpg\" class=\"image\"><img alt=\"Ritalin-SR-20mg-1000x1000.jpg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a9/Ritalin-SR-20mg-1000x1000.jpg/220px-Ritalin-SR-20mg-1000x1000.jpg\" width=\"220\" height=\"220\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a9/Ritalin-SR-20mg-1000x1000.jpg/330px-Ritalin-SR-20mg-1000x1000.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a9/Ritalin-SR-20mg-1000x1000.jpg/440px-Ritalin-SR-20mg-1000x1000.jpg 2x\" data-file-width=\"1168\" data-file-height=\"1168\" /></a></td></tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<a href=\"/wiki/Prescription_drugs\" class=\"mw-redirect\" title=\"Prescription drugs\">Prescription drugs</a> <br /> <a href=\"/wiki/Over-the-counter_drugs\" class=\"mw-redirect\" title=\"Over-the-counter drugs\">Over-the-counter drugs</a></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left\">Law</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><a href=\"/wiki/Federal_Food,_Drug,_and_Cosmetic_Act\" title=\"Federal Food, Drug, and Cosmetic Act\">Federal Food, Drug, and Cosmetic Act</a><br /><a href=\"/wiki/Comprehensive_Drug_Abuse_Prevention_and_Control_Act_of_1970\" title=\"Comprehensive Drug Abuse Prevention and Control Act of 1970\">Comprehensive Drug Abuse Prevention and Control Act of 1970</a><br /><a href=\"/wiki/Controlled_Substances_Act\" title=\"Controlled Substances Act\">Controlled Substances Act</a><br /><a href=\"/wiki/Prescription_Drug_Marketing_Act\" title=\"Prescription Drug Marketing Act\">Prescription Drug Marketing Act</a><br /><a href=\"/wiki/Drug_Price_Competition_and_Patent_Term_Restoration_Act\" title=\"Drug Price Competition and Patent Term Restoration Act\">Drug Price Competition and Patent Term Restoration Act</a><br /><a href=\"/wiki/Hatch-Waxman_exemption\" class=\"mw-redirect\" title=\"Hatch-Waxman exemption\">Hatch-Waxman exemption</a><br /><a href=\"/wiki/Marihuana_Tax_Act\" class=\"mw-redirect\" title=\"Marihuana Tax Act\">Marihuana Tax Act</a></div></div></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left\">Government agencies</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><a href=\"/wiki/United_States_Department_of_Health_and_Human_Services\" title=\"United States Department of Health and Human Services\">Department of Health and Human Services</a><br /><a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a><br /><a href=\"/wiki/United_States_Department_of_Justice\" title=\"United States Department of Justice\">Department of Justice</a><br /><a href=\"/wiki/Drug_Enforcement_Administration\" title=\"Drug Enforcement Administration\">Drug Enforcement Administration</a></div></div></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left\">Process</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><a href=\"/wiki/Drug_discovery\" title=\"Drug discovery\">Drug discovery</a><br /><a href=\"/wiki/Drug_design\" title=\"Drug design\">Drug design</a><br /><a href=\"/wiki/Drug_development\" title=\"Drug development\">Drug development</a><br /><a href=\"/wiki/New_drug_application\" class=\"mw-redirect\" title=\"New drug application\">New drug application</a><br /><a href=\"/wiki/Investigational_new_drug\" class=\"mw-redirect\" title=\"Investigational new drug\">Investigational new drug</a><br /><a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trial</a> (Phase I, II, III, IV)<br /><a href=\"/wiki/Randomized_controlled_trial\" title=\"Randomized controlled trial\">Randomized controlled trial</a><br /><a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">Pharmacovigilance</a><br /><a href=\"/wiki/Abbreviated_New_Drug_Application\" title=\"Abbreviated New Drug Application\">Abbreviated New Drug Application</a><br /><a href=\"/wiki/FDA_Fast_Track_Development_Program\" class=\"mw-redirect\" title=\"FDA Fast Track Development Program\">Fast track approval</a><br /><a href=\"/wiki/Off-label_use\" title=\"Off-label use\">Off-label use</a></div></div></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left\">International coordination</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><a href=\"/wiki/International_Conference_on_Harmonisation_of_Technical_Requirements_for_Registration_of_Pharmaceuticals_for_Human_Use\" class=\"mw-redirect\" title=\"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use\">International Conference on Harmonisation of Technical<br />Requirements for Registration of Pharmaceuticals for Human Use</a><br /><a href=\"/wiki/Uppsala_Monitoring_Centre\" title=\"Uppsala Monitoring Centre\">Uppsala Monitoring Centre</a><br /><a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a><br /><a href=\"/wiki/Council_for_International_Organizations_of_Medical_Sciences\" title=\"Council for International Organizations of Medical Sciences\">Council for International Organizations of Medical Sciences</a><br /><a href=\"/wiki/Single_Convention_on_Narcotic_Drugs\" title=\"Single Convention on Narcotic Drugs\">Single Convention on Narcotic Drugs</a></div></div></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;padding-right:2em;background:transparent;text-align:left;\">Non-governmental organizations</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><a href=\"/wiki/Institute_of_Medicine\" class=\"mw-redirect\" title=\"Institute of Medicine\">Institute of Medicine</a><br /><a href=\"/wiki/Research_on_Adverse_Drug_events_And_Reports\" class=\"mw-redirect\" title=\"Research on Adverse Drug events And Reports\">Research on Adverse Drug events And Reports</a><br /><a href=\"/wiki/NORML\" class=\"mw-redirect\" title=\"NORML\">NORML</a></div></div></td>\n</tr><tr><td style=\"text-align:right;font-size:115%;padding-top: 0.6em;\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Regulation_of_therapeutic_goods_in_the_United_States\" title=\"Template:Regulation of therapeutic goods in the United States\"><abbr title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Regulation_of_therapeutic_goods_in_the_United_States\" title=\"Template talk:Regulation of therapeutic goods in the United States\"><abbr title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Regulation_of_therapeutic_goods_in_the_United_States&amp;action=edit\"><abbr title=\"Edit this template\">e</abbr></a></li></ul></div></td></tr></tbody></table>\n<p><b>Research on Adverse Drug Events and Reports (RADAR)</b> is a <a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">pharmacovigilance</a> team of 25 doctors who receive calls about possible <a href=\"/wiki/Adverse_drug_reaction\" title=\"Adverse drug reaction\">adverse drug reactions</a> (ADR) and investigate.  RADAR is based at <a href=\"/wiki/Northwestern_University\" title=\"Northwestern University\">Northwestern</a>'s <a href=\"/wiki/Feinberg_School_of_Medicine\" title=\"Feinberg School of Medicine\">Feinberg School of Medicine</a>. RADAR is led by Dennis West. Though it was without funding for its first four years, RADAR has raised about $12 million through grants from the <a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">National Institutes of Health</a>, the <a href=\"/wiki/American_Cancer_Society\" title=\"American Cancer Society\">American Cancer Society</a> and other such institutions. Its work has identified safety problems with 33 drugs.  <a href=\"/wiki/Adverse_drug_events\" class=\"mw-redirect\" title=\"Adverse drug events\">Adverse drug events</a> are a serious health problem.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Aims\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Aims</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Results\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Results</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Methods\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Methods</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Strengths\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Strengths</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Specific_ADR_reports_by_RADAR\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Specific ADR reports by RADAR</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Aims\">Aims</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Research_on_Adverse_Drug_Events_and_Reports&amp;action=edit&amp;section=1\" title=\"Edit section: Aims\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The aims of RADAR are to disseminate safety reports for serious adverse drug reactions (sADRs) and to identify barriers to identification and reporting of these clinical events. Investigators have developed a well-coordinated system to accurately compile case report information on sADRs and to identify milestones associated with identification and reporting of the relevant ADR information. This ADR identification system allows us to amass pertinent sADR information from a diverse set of data sources in order to identify and report sADRs in a timely and thorough manner. With increasingly shortened review periods, <a href=\"/wiki/Postmarketing_surveillance\" title=\"Postmarketing surveillance\">postmarketing surveillance</a> for sADRs has become very important. In some instances, initial cases are identified at hospital case conferences and reported to the <a href=\"/wiki/Food_and_Drug_Administration_(United_States)\" class=\"mw-redirect\" title=\"Food and Drug Administration (United States)\">U.S. Food and Drug Administration</a> (FDA) or to the <a href=\"/wiki/Pharmaceutical_manufacturer\" class=\"mw-redirect\" title=\"Pharmaceutical manufacturer\">pharmaceutical manufacturer</a>. The RADAR methodology relies on initial recognition of these \u201csentinel\u201d cases that then prompts hypothesis\u2013driven inquiries as to whether an unrecognized <a href=\"/wiki/Adverse_drug_reaction\" title=\"Adverse drug reaction\">adverse drug event</a> signal is present in the population of those exposed to that drug.\n</p>\n<h2><span class=\"mw-headline\" id=\"Results\">Results</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Research_on_Adverse_Drug_Events_and_Reports&amp;action=edit&amp;section=2\" title=\"Edit section: Results\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Between 1998 and 2007, 33 serious adverse drug or device reactions have been reported by RADAR investigators. The <a href=\"/wiki/Toxicity\" title=\"Toxicity\">toxicities</a> involved multiple <a href=\"/wiki/Organ_systems\" class=\"mw-redirect\" title=\"Organ systems\">biological system</a> and included <a href=\"/wiki/Thrombotic_thrombocytopenic_purpura\" title=\"Thrombotic thrombocytopenic purpura\">thrombotic thrombocytopenic purpura</a> (TTP) (<a href=\"/wiki/Ticlopidine\" title=\"Ticlopidine\">ticlopidine</a> and <a href=\"/wiki/Clopidogrel\" title=\"Clopidogrel\">clopidogrel</a>), <a href=\"/wiki/Thromboembolism\" class=\"mw-redirect\" title=\"Thromboembolism\">thromboembolism</a> (<a href=\"/wiki/Thalidomide\" title=\"Thalidomide\">thalidomide</a> and <a href=\"/wiki/Lenalidomide\" title=\"Lenalidomide\">lenalidomide</a>), <a href=\"/wiki/Liver_failure\" title=\"Liver failure\">liver failure</a> (<a href=\"/wiki/Gemtuzumab\" class=\"mw-redirect\" title=\"Gemtuzumab\">gemtuzumab</a> and <a href=\"/wiki/Nevirapine\" title=\"Nevirapine\">nevirapine</a>), <a href=\"/wiki/Hypersensitivity\" title=\"Hypersensitivity\">hypersensitivity</a> (<a href=\"/wiki/Drug-eluting_stent\" title=\"Drug-eluting stent\">drug eluting coronary arterial stents</a>), <a href=\"/wiki/Acquired_pure_red_cell_aplasia\" class=\"mw-redirect\" title=\"Acquired pure red cell aplasia\">pure red-cell aplasia</a> (PRCA) (<a href=\"/wiki/Epoetin\" class=\"mw-redirect\" title=\"Epoetin\">epoetin</a>), vision changes (<a href=\"/wiki/Amiodarone\" title=\"Amiodarone\">amiodarone</a>, <a href=\"/wiki/Sildenafil\" title=\"Sildenafil\">sildenafil</a>, and <a href=\"/wiki/Tadalafil\" title=\"Tadalafil\">tadalafil</a>), late <a href=\"/wiki/Thrombosis\" title=\"Thrombosis\">thrombotic events</a> (<a href=\"/wiki/Drug-eluting_stent\" title=\"Drug-eluting stent\">drug eluting cardiac stents</a>), <a href=\"/wiki/Leukemia\" title=\"Leukemia\">leukemia</a> (<a href=\"/wiki/G-CSF\" class=\"mw-redirect\" title=\"G-CSF\">G-CSF</a>), and <a href=\"/wiki/Interstitial_pneumonitis\" class=\"mw-redirect\" title=\"Interstitial pneumonitis\">interstitial pneumonitis</a> (<a href=\"/wiki/Gemcitabine\" title=\"Gemcitabine\">gemcitabine</a>). For each individual ADR, the number of unique event reports collected by RADAR ranged from 0 to 96. Twenty-seven sADRs were associated with drugs and four were associated with a device.\n</p>\n<h2><span class=\"mw-headline\" id=\"Methods\">Methods</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Research_on_Adverse_Drug_Events_and_Reports&amp;action=edit&amp;section=3\" title=\"Edit section: Methods\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The success of the RADAR program has previously been largely based on the use of diverse data sources to identify, clarify, and verify ADRs.  <a href=\"/wiki/Databases\" class=\"mw-redirect\" title=\"Databases\">Databases</a>, <a href=\"https://en.wiktionary.org/wiki/registry\" class=\"extiw\" title=\"wikt:registry\">registries</a>, <a href=\"/wiki/Clinical_trials\" class=\"mw-redirect\" title=\"Clinical trials\">clinical trials</a>, referral centers, and case reports have all been utilized as sites of detection. In particular, RADAR has made use of reports submitted to <a href=\"/wiki/MedWatch\" title=\"MedWatch\">MedWatch</a> as well as more focused databases such as the <a href=\"/wiki/Medicare_(United_States)\" title=\"Medicare (United States)\">Medicare</a>-SEER database. Hypothesis-driven active surveillance of a few hundred safety reports serves as the underlying conceptual framework of RADAR <a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">pharmacovigilance</a>. Fewer than 20 individual ADR reports led to RADAR investigators identifying safety signals for the majority of the ADRs described to date. Despite a small number of reports for each ADR, <a href=\"/wiki/Causality\" title=\"Causality\">causality</a> assessments have been supported by <a href=\"/wiki/Pathology\" title=\"Pathology\">pathology</a> studies, <a href=\"/wiki/Antibody\" title=\"Antibody\">antibody</a> studies, and <a href=\"/wiki/Autopsies\" class=\"mw-redirect\" title=\"Autopsies\">autopsies</a>. For example, the initial description of <a href=\"/wiki/Thrombotic_thrombocytopenic_purpura\" title=\"Thrombotic thrombocytopenic purpura\">thrombotic thrombocytopenic purpura</a> associated with <a href=\"/wiki/Clopidogrel\" title=\"Clopidogrel\">clopidogrel</a> included only 11 cases. \n</p>\n<h2><span class=\"mw-headline\" id=\"Strengths\">Strengths</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Research_on_Adverse_Drug_Events_and_Reports&amp;action=edit&amp;section=4\" title=\"Edit section: Strengths\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>RADAR has also identified key barriers to timely and efficiently identifying ADRs and to comprehensively reporting these findings. In particular, we identified quality concerns with MedWatch reports (the FDA\u2019s primary source of adverse event reports) and poor quality of dissemination of adverse event findings from the FDA and the <a href=\"/wiki/Pharmaceutical\" class=\"mw-redirect\" title=\"Pharmaceutical\">pharmaceutical</a> sponsor. Our efforts have found that RADAR sADR identification and dissemination efforts can be as rapid as one to two years after FDA approval, in contrast to the seven years generally seen with safety efforts from the FDA and pharmaceutical sponsors. Thus, the RADAR project has developed into an important adjunct to the current pharmaceutical drug and device safety system.\n</p>\n<h2><span class=\"mw-headline\" id=\"Specific_ADR_reports_by_RADAR\">Specific ADR reports by RADAR</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Research_on_Adverse_Drug_Events_and_Reports&amp;action=edit&amp;section=5\" title=\"Edit section: Specific ADR reports by RADAR\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>RADAR has analyzed historical data on many drugs from their initial inception, through approval by the FDA, and to the \npresent.  These analyses synthesize the various sources of statistical information on the presence of adverse reactions to these drugs and assess whether the actual risk is in line with studies.\n</p>\n<!-- \nNewPP limit report\nParsed by mw2208\nCached time: 20180916095028\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.080 seconds\nReal time usage: 0.105 seconds\nPreprocessor visited node count: 215/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 16800/2097152 bytes\nTemplate argument size: 13/2097152 bytes\nHighest expansion depth: 6/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 0/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.025/10.000 seconds\nLua memory usage: 1.01 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   63.706      1 -total\n 76.94%   49.015      1 Template:Unreferenced\n 50.30%   32.044      1 Template:Ambox\n 22.93%   14.605      1 Template:Regulation_of_therapeutic_goods_in_the_United_States\n 19.10%   12.165      1 Template:Sidebar_with_collapsible_lists\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:12667794-0!canonical and timestamp 20180916095028 and revision id 753200215\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"Research On Adverse Drug Events And Reports","hidden":"","*":"Articles_lacking_sources_from_December_2016"},{"sortkey":"Research On Adverse Drug Events And Reports","hidden":"","*":"All_articles_lacking_sources"},{"sortkey":"Research On Adverse Drug Events And Reports","*":"Clinical_pharmacology"},{"sortkey":"Research On Adverse Drug Events And Reports","*":"Clinical_research"}],"links":[{"ns":14,"exists":"","*":"Category:Articles lacking sources from December 2016"},{"ns":0,"exists":"","*":"Research on Adverse Drug events And Reports"},{"ns":0,"exists":"","*":"Abbreviated New Drug Application"},{"ns":0,"exists":"","*":"Acquired pure red cell aplasia"},{"ns":0,"exists":"","*":"Adverse drug events"},{"ns":0,"exists":"","*":"Adverse drug reaction"},{"ns":0,"exists":"","*":"American Cancer Society"},{"ns":0,"exists":"","*":"Amiodarone"},{"ns":0,"exists":"","*":"Antibody"},{"ns":0,"exists":"","*":"Autopsies"},{"ns":0,"exists":"","*":"Causality"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Clinical trials"},{"ns":0,"exists":"","*":"Clopidogrel"},{"ns":0,"exists":"","*":"Comprehensive Drug Abuse Prevention and Control Act of 1970"},{"ns":0,"exists":"","*":"Controlled Substances Act"},{"ns":0,"exists":"","*":"Council for International Organizations of Medical Sciences"},{"ns":0,"exists":"","*":"Databases"},{"ns":0,"exists":"","*":"Drug-eluting stent"},{"ns":0,"exists":"","*":"Drug Enforcement Administration"},{"ns":0,"exists":"","*":"Drug Price Competition and Patent Term Restoration Act"},{"ns":0,"exists":"","*":"Drug design"},{"ns":0,"exists":"","*":"Drug development"},{"ns":0,"exists":"","*":"Drug discovery"},{"ns":0,"exists":"","*":"Epoetin"},{"ns":0,"exists":"","*":"FDA Fast Track Development Program"},{"ns":0,"exists":"","*":"Federal Food, Drug, and Cosmetic Act"},{"ns":0,"exists":"","*":"Feinberg School of Medicine"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Food and Drug Administration (United States)"},{"ns":0,"exists":"","*":"G-CSF"},{"ns":0,"exists":"","*":"Gemcitabine"},{"ns":0,"exists":"","*":"Gemtuzumab"},{"ns":0,"exists":"","*":"Hatch-Waxman exemption"},{"ns":0,"exists":"","*":"Hypersensitivity"},{"ns":0,"exists":"","*":"Institute of Medicine"},{"ns":0,"exists":"","*":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use"},{"ns":0,"exists":"","*":"Interstitial pneumonitis"},{"ns":0,"exists":"","*":"Investigational new drug"},{"ns":0,"exists":"","*":"Lenalidomide"},{"ns":0,"exists":"","*":"Leukemia"},{"ns":0,"exists":"","*":"Liver failure"},{"ns":0,"exists":"","*":"Marihuana Tax Act"},{"ns":0,"exists":"","*":"MedWatch"},{"ns":0,"exists":"","*":"Medicare (United States)"},{"ns":0,"exists":"","*":"NORML"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"Nevirapine"},{"ns":0,"exists":"","*":"New drug application"},{"ns":0,"exists":"","*":"Northwestern University"},{"ns":0,"exists":"","*":"Off-label use"},{"ns":0,"exists":"","*":"Organ systems"},{"ns":0,"exists":"","*":"Over-the-counter drugs"},{"ns":0,"exists":"","*":"Pathology"},{"ns":0,"exists":"","*":"Pharmaceutical"},{"ns":0,"exists":"","*":"Pharmaceutical manufacturer"},{"ns":0,"exists":"","*":"Pharmacovigilance"},{"ns":0,"exists":"","*":"Postmarketing surveillance"},{"ns":0,"exists":"","*":"Prescription Drug Marketing Act"},{"ns":0,"exists":"","*":"Prescription drugs"},{"ns":0,"exists":"","*":"Randomized controlled trial"},{"ns":0,"exists":"","*":"Sildenafil"},{"ns":0,"exists":"","*":"Single Convention on Narcotic Drugs"},{"ns":0,"exists":"","*":"Tadalafil"},{"ns":0,"exists":"","*":"Thalidomide"},{"ns":0,"exists":"","*":"Thromboembolism"},{"ns":0,"exists":"","*":"Thrombosis"},{"ns":0,"exists":"","*":"Thrombotic thrombocytopenic purpura"},{"ns":0,"exists":"","*":"Ticlopidine"},{"ns":0,"exists":"","*":"Toxicity"},{"ns":0,"exists":"","*":"United States Department of Health and Human Services"},{"ns":0,"exists":"","*":"United States Department of Justice"},{"ns":0,"exists":"","*":"Uppsala Monitoring Centre"},{"ns":0,"exists":"","*":"World Health Organization"},{"ns":10,"exists":"","*":"Template:Regulation of therapeutic goods in the United States"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":11,"exists":"","*":"Template talk:Regulation of therapeutic goods in the United States"},{"ns":12,"exists":"","*":"Help:Introduction to referencing with Wiki Markup/1"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Unreferenced"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Regulation of therapeutic goods in the United States"},{"ns":10,"exists":"","*":"Template:Sidebar with collapsible lists"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Sidebar"},{"ns":828,"exists":"","*":"Module:Navbar"}],"images":["Question_book-new.svg","Ritalin-SR-20mg-1000x1000.jpg"],"externallinks":[],"sections":[{"toclevel":1,"level":"2","line":"Aims","number":"1","index":"1","fromtitle":"Research_on_Adverse_Drug_Events_and_Reports","byteoffset":726,"anchor":"Aims"},{"toclevel":1,"level":"2","line":"Results","number":"2","index":"2","fromtitle":"Research_on_Adverse_Drug_Events_and_Reports","byteoffset":1919,"anchor":"Results"},{"toclevel":1,"level":"2","line":"Methods","number":"3","index":"3","fromtitle":"Research_on_Adverse_Drug_Events_and_Reports","byteoffset":2926,"anchor":"Methods"},{"toclevel":1,"level":"2","line":"Strengths","number":"4","index":"4","fromtitle":"Research_on_Adverse_Drug_Events_and_Reports","byteoffset":3984,"anchor":"Strengths"},{"toclevel":1,"level":"2","line":"Specific ADR reports by RADAR","number":"5","index":"5","fromtitle":"Research_on_Adverse_Drug_Events_and_Reports","byteoffset":4729,"anchor":"Specific_ADR_reports_by_RADAR"}],"parsewarnings":[],"displaytitle":"Research on Adverse Drug Events and Reports","iwlinks":[{"prefix":"wikt","url":"https://en.wiktionary.org/wiki/registry","*":"wikt:registry"}],"properties":[{"name":"defaultsort","*":"Research On Adverse Drug Events And Reports"},{"name":"wikibase_item","*":"Q7315166"}]}}